Jonathan E. Valuck, MD, in Oklahoma City: Interventional Cardiology and Structural Heart Disease

Jonathan E. Valuck is an interventional cardiologist in Oklahoma City whose practice centers on structural heart disease, including transcatheter aortic valve replacement (TAVR) and patent foramen ovale (PFO) closure. He brings subspecialty focus to a market where most cardiologists manage general coronary artery disease and heart failure, making him a referral destination for patients whose anatomy or risk factors require advanced catheter-based treatment rather than surgical repair.

What Valuck actually is

Valuck holds board certification in cardiology and interventional cardiology and directs the Structural Heart Program, placing him in a narrow clinical tier. Oklahoma City's cardiology landscape includes general practitioners who perform stress tests and manage medications, as well as larger practices offering coronary angiography and stent placement. Valuck's distinction lies in procedures that require real-time imaging, patient selection expertise, and case-by-case judgment about whether a patient is a candidate for a catheter approach or needs surgery instead.

Structural heart disease encompasses abnormalities in the heart's valves or septum. In Oklahoma City, most patients with aortic valve stenosis have historically been referred to surgeons for valve replacement. TAVR, approved by the FDA in 2011 and expanding in indication, is less invasive and has become the preferred approach for many patients over age 75 or those at high surgical risk. PFO closure addresses a small hole between the upper chambers, typically found in young patients after a stroke of unclear origin. Valuck's expertise centers on determining candidacy, sizing devices, and executing these procedures under fluoroscopic and echocardiographic guidance.

Services and typical referral patterns

Valuck evaluates patients for TAVR, often after an echocardiogram and clinical assessment by the referring physician have identified severe aortic stenosis. The consultation includes a detailed cardiac catheterization to assess coronary circulation and measure valve anatomy. If a patient is deemed suitable, TAVR is typically scheduled as an inpatient procedure, often performed under monitored anesthesia or light sedation, with one to two nights of hospitalization. Recovery to independent mobility often takes two to four weeks.

PFO closure also begins with imaging (usually transesophageal echocardiography) to visualize the defect and confirm it as a stroke risk factor. If closure is indicated, the procedure is performed under sedation and usually requires an overnight stay. Patients are discharged on dual antiplatelet therapy for three to six months.

Oklahoma City cardiologists at larger health systems (OU Medical Center, Mercy Health System, Integris) offer general coronary intervention and device therapy for heart failure but do not consistently perform TAVR or PFO closure in-house. For patients needing these procedures, referral to Valuck or similar subspecialists within Oklahoma City reduces travel compared to seeking care in Dallas or Kansas City.

Specific pricing for TAVR or PFO closure is facility-determined and insurance-dependent; out-of-pocket costs vary significantly based on deductible and coverage. Patients should confirm with their insurance whether Valuck's hospital affiliation is in-network and what their procedural cost-sharing will be before scheduling consultation.

How Valuck compares to other cardiologists in Oklahoma City

Valuck's structural heart focus is not replicated by most general cardiologists in Oklahoma City. Cardiologists in Oklahoma City who perform coronary angiography and percutaneous coronary intervention (PCI, or stent placement) number in the dozens and are available through multiple health systems; they handle the most common cardiac procedures. Valuck represents a second tier: a specialist whose scope is narrower but whose training and procedural volume in structural disease exceed that of a generalist.

For a patient with aortic stenosis, the choice between seeing Valuck first versus seeing a general cardiologist depends on symptom severity and surgical risk. Patients with severe, symptomatic aortic stenosis who are deemed high-risk for surgery should be referred to a structural heart specialist directly. Younger, lower-risk patients may be managed initially by a cardiologist and referred to Valuck only if surgery is deemed inappropriate or if the patient requests a less invasive option.

For PFO closure, few Oklahoma City cardiologists maintain the imaging and closure expertise; most will refer to a structural specialist, making Valuck a practical in-state option that avoids referral to a regional academic center.

Who Valuck suits and who he does not

Valuck's practice is appropriate for patients aged 65 and older with severe aortic stenosis who are symptomatic (shortness of breath, syncope, angina) and either too frail or too high-risk for surgery, or who prefer a less invasive approach. He also manages younger, lower-risk patients who meet imaging criteria for TAVR if they request it.

Patients with PFO and a cryptic stroke (one without another identified cause) are candidates for his evaluation. Patients with asymptomatic PFO found incidentally (e.g., during an unrelated echocardiogram) are not typically referred for closure, as closure does not prevent stroke in that population.

Patients with uncomplicated coronary artery disease, heart failure managed on medications, or arrhythmias do not require Valuck; they are better served by a general cardiologist or arrhythmia specialist. Patients seeking a first-opinion cardiology assessment should start with a general cardiologist unless already referred specifically for structural disease.

What a first visit involves

An initial consultation for TAVR or PFO closure includes a history and physical examination, review of imaging (prior echocardiogram, CT angiography if available), and often a diagnostic cardiac catheterization on the same day or scheduled shortly after. The catheterization allows direct measurement of gradients across a stenotic valve or visualization of coronary anatomy to ensure the patient is safe for the procedure. The visit concludes with discussion of candidacy, procedural options, risks, and recovery.

For PFO evaluation, a transesophageal echocardiogram (TEE) is performed to visualize the defect and assess septal anatomy. If closure is appropriate, it may be scheduled within weeks or months, depending on urgency and the treating stroke service's assessment of recurrent risk.

Hours, location, and logistics

Valuck's practice is located within a health system facility in Oklahoma City, with consultation hours during standard business days. Procedures are performed at the associated hospital's catheterization laboratory, which is equipped for complex imaging and device placement. Parking is available on-site or at the main hospital campus.

Procedural scheduling typically has a lead time of two to six weeks, depending on urgency and hospital operating room availability. Patients should confirm hours and current procedural schedules with the office, as structural heart programs manage demand based on available imaging and staffing.

Valuck fills a clinical gap in Oklahoma City's cardiology market by delivering subspecialty expertise in structural disease without requiring patients to travel for TAVR or PFO closure.